Company | Recipients N | Response N (%) | Recipients N | Response N (%) | Recipients N | Response N (%) | Recipients N | Response N (%) |
---|---|---|---|---|---|---|---|---|
T0: pre-treatment assessment | T1: Screening, diagnostic assessment and initiation of treatment | T2: 6-month follow-up | T3: 12-month follow-up | |||||
1. Public service | 163 | 107 (65.6) | 167 | 101 (60.5) | 170 | 96 (56.5) | 180 | 100 (55.6) |
2. Public service | 166 | 100 (60.2) | 167 | 94 (56.3) | 170 | 106 (62.4) | 160 | 97 (60.6) |
3. Private, financial | 251 | 181 (72.1) | 240 | 161 (67.1) | 247 | 161 (65.2) | 246 | 166 (67.5) |
4. Private, manufacturing | 148 | 74 (50.0) | 162 | 71 (43.8) | 165 | 71 (43.0) | 156 | 69 (44.2) |
5. Private, manufacturing | 125 | 59 (47.2) | 130 | 55 (42.3) | 135 | 50 (37.0) | 139 | 59 (42.4) |
6. Public, education | 198 | 88 (44.4) | 202 | 92 (45.5) | 185 | 82 (44.3) | 182 | 72 (39.6) |
Total | 1051 | 609 (57.9) | 1068 | 586 (54.9) | 1072 | 566 (52.8) | 1063 | 563 (53.0) |